fibrinogen has been researched along with Diabetic Angiopathies in 144 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 54 (37.50) | 18.7374 |
1990's | 42 (29.17) | 18.2507 |
2000's | 33 (22.92) | 29.6817 |
2010's | 15 (10.42) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chalmers, J; Hamet, P; Harrap, S; Hillis, G; Li, Q; Lowe, G; Marre, M; Patel, A; Poulter, N; Rumley, A; Woodward, M | 1 |
Akalin, A; Arabul, M; Celik, M; Cerrah, S | 1 |
Ajjan, RA; Grant, PJ; Grove, EL; Hvas, AM; Kristensen, SD; Kurdee, Z; Larsen, SB; Neergaard-Petersen, S; Phoenix, F | 1 |
C-K Chou, C; Cheng, TJ; Li, YR; Lo, K; Tung, CL; Wang, JS; Yan, YH | 1 |
Aimaretti, G; Barbieri, L; Bellomo, G; De Luca, G; Di Giovine, G; Marino, P; Schaffer, A; Sinigaglia, F; Suryapranata, H; Verdoia, M | 1 |
Kang, Z; Wang, FJ; Yao, HQ | 1 |
Chadli, A; El Aziz, S; El Hammiri, A; Farouqi, A; Ghalim, N; Habbal, R; Kabine, M; Kamal, N; Kotbi, S; Mifdal, H; Mjabber, A; Nourichafi, N; Oukkache, B | 1 |
Cornell, E; Knowler, WC; Krakoff, J; Le, DS; Miles, R; Savage, PJ; Tracy, RP | 1 |
Krysiak, R; Okopien, B; Pruski, M | 1 |
Abregu, AV; Bazán, MC; Del R Carrizo, T; Díaz, EI; Fonio, MC; Prado, MM; Velarde, MS | 1 |
Guliani, BP; Gupt, B; Kansra, UC; Madan, R; Saluja, S; Tripathi, BK | 1 |
de Gorospe Pérez-Jáuregui, C; Del Cañizo Gómez, FJ; Fernández Pérez, C; González Losada, T; Moreno Ruiz, I; Segura Galindo, A; Silveira Rodríguez, B | 1 |
Cheng, YS; Li, MH; Liu, F; Tan, HQ; Wang, J; Wang, JB; Zhao, JG; Zhu, YQ | 1 |
Berg, JP; Hanssen, KF; Jensen, AB; Kilhovd, B; Lund, T; Pepaj, M; Svindland, A | 1 |
Antonova, N; Damianov, P; Dimitrova, V; Mantarova, S; Stoyneva, Z; Velcheva, I | 1 |
Antonova, N; Damianov, P; Mantarova, S; Velcheva, I | 1 |
Festa, A; Goodarzi, MO; Haffner, SM; Hanley, AJ; Lee, CC; Lorenzo, C; Norris, JM; Olson, NC; Rewers, MJ; Stefanovski, D; Wagenknecht, LE | 1 |
Hanefeld, M; Henkel, E; Koehler, C; Temelkova-Kurktschiev, T | 1 |
Clore, J; Garvey, WT; Hunter, SJ; Jenkins, AJ; Klein, RL; Semler, AJ; Zheng, D | 1 |
HUME, R; MACKAY, N | 1 |
Martin, F; Martin-Luengo, C; Morinigo, JL; Pabon, P; Palacios, IF; Piedra, I; Sanchez, PL | 1 |
Biro, F; Kuegler, C; Michler, E; Rudofsky, G; Strubel, G | 1 |
Fisher, M; Kirk, A; MacIntyre, P; Mutrie, N | 1 |
Khodabandehlou, T; Le Dévéhat, C; Vimeux, M | 2 |
Ariëns, RA; Dunn, EJ | 1 |
Cozma, A; Negrean, V; Sâmpelean, D; Suciu, I | 1 |
Agardh, CD; Gustavsson, CG | 1 |
Assayag, EB; Berliner, S; Bonet, DS; Bornstein, N; Burke, M; Goldin, Y; Mardi, T; Shapira, I; Tolshinski, T; Vered, Y; Zakuth, V | 1 |
Bargero, G; Biggeri, A; Bruno, G; Cavallo-Perin, P; Ferrero, S; Merletti, F; Pagano, G | 1 |
Ariëns, RA; Dunn, EJ; Grant, PJ | 1 |
Bertolini, L; Falezza, G; Targher, G; Zenari, L; Zoppini, G | 1 |
Abregu, AV; Bazan, MC; Carrizo, Tdel R; Diaz, EI; Fonio, MC; Perez Aguilar, RC; Prado, MM; Velarde, MS | 1 |
Bevelacqua, V; Bevelacqua, Y; Libra, M; Malaponte, G; Mazzarino, MC; Navolanic, PM; Polesel, J; Signorelli, SS; Stivala, F; Talamini, R | 1 |
Aso, Y; Inukai, T; Matsutomo, R; Suetsugu, M; Takebayashi, K; Wakabayashi, S | 1 |
Festa, A; Haffner, SM; Tracy, RP; Wagenknecht, LE; Williams, K | 1 |
Borozanov, V; Bosevski, M; Georgievska-Ismail, L; Peovska, I | 1 |
Chaturvedi, N; Fuller, JH; Pickup, JC; Soedamah-Muthu, SS | 1 |
Berger, W; Christe, M; Duckert, F; Fritschi, J; Lämmle, B; Marbet, GA; Tran, TH | 1 |
Burrows, AW | 1 |
Dupuy, E; Guillausseau, PJ; Lubetzki, J | 1 |
Fuller, JH | 1 |
Hegewisch, S; Koepp, P | 1 |
Dormandy, JA | 1 |
Beiküfner, P; Panzram, G; Schmechel, H | 1 |
Bodnar, PN; Buglak, NI; Donish, RM; Panasiukova, OR | 1 |
Bucalossi, A; Corri, S; Di Noto, C; Marsilii, A; Petruzzi, E | 1 |
Auriemma, L; Di Martino, G; Florio, A; Iannucci, F; Matarazzo, A; Rosati, V | 1 |
Adjizian, JC; Droulle, C; Janody, D; Jeunehomme, G; Leutenegger, M; Ostermann, G; Potron, G; Poynard, JP | 1 |
Isogai, S; Kameyama, M; Urayama, T | 1 |
Amado, JA; Mazo, E; Sedano, MC; Vadillo, V; Vidal, JI | 1 |
Abadie, E; Caen, JP; Passa, P; Paton, RC; Pintigny, D; Wautier, JL; Wautier, MP | 1 |
McMillan, DE | 1 |
Caimi, G; Catania, A; Francavilla, G; La Bruzzo, S; Romano, A; Sarno, A | 2 |
Hermansen, K; Ingerslev, J; Rasmussen, O; Thomsen, C | 1 |
Brismar, K; Fagrell, B; Jörneskog, G | 1 |
Seidel, D | 1 |
Abendroth, D; Land, W; Landgraf, R; Pfeiffer, M; Reininger, J; Seidel, D | 1 |
Buysschaert, M; Chatelain, B; Donckier, J; el Khawand, C; Jamart, J; Lavenne, E; Moriau, M | 1 |
Aoshima, K; Asakura, H; Hashimoto, T; Jokaji, H; Kumabashiri, I; Matsuda, T; Morishita, E; Saito, M; Uotani, C; Yamazaki, M | 1 |
Harano, Y; Hattori, Y; Inada, H; Inoue, J; Ito, H; Kawamori, R; Murase, T; Nawata, H; Orimo, H; Ouchi, Y; Suzuki, M; Takeuchi, M; Umeda, F | 1 |
Biesenbach, G; Zazgornik, J | 1 |
de Leonardis, V; Lombardi, V; Perfetto, F; Piluso, A; Tarquini, B; Tarquini, R | 1 |
Carter, AM; Grant, PJ; Mansfield, MW; Stickland, MH | 1 |
Boda, Z; Udvardy, M | 1 |
Greenhalgh, RM; Hicks, RC; Higman, DJ; Moss, J; Powell, JT | 1 |
Andreani, D; Arcieri, P; Bosco, D; Ciampalini, P; Gargiulo, P; Pantaleo, A; Romani, B; Schiaffini, R | 1 |
Ewald, U; Sandhagen, B; Tuvemo, T | 1 |
Fuller, JH; Goodfellow, K; Greaves, M; Malia, RG; Mattock, M; Stephenson, JM; Stevens, LK | 1 |
Ceriello, A | 1 |
Carmassi, F; De Negri, F; Morale, M | 1 |
Juhan-Vague, I; Vague, P | 1 |
Mojto, V | 1 |
Honda, Y; Kenmochi, S; Miyamoto, K; Ogura, Y | 1 |
Molcányiová, A; Tkác, I | 1 |
Bortolotti, N; Ceriello, A; Crescentini, A; Giacomello, R; Motz, E; Pirisi, M; Russo, A; Stel, G; Taboga, C; Tonutti, L | 1 |
Deckert, T; Gram, J; Jensen, T; Jespersen, J; Kluft, C; Myrup, B | 1 |
Balza, G; Cerutti, N; Ferrari, E; Fioravanti, M; Locatelli, M; Pezza, N; Rondanelli, M; Severgnini, S; Solerte, SB; Trecate, L | 1 |
Faust, H; Haak, E; Haak, T; Kusterer, K; Reschke, B; Usadel, KH | 1 |
Byington, RP; Di Mauro, P; Guarisco, R; Pahor, M; Strollo, F; Strollo, G; Tatti, P | 1 |
Dhanjil, S; Diamond, JR; Elkeles, RS; Feher, MD; Mahmood, S; Mather, H; Nicolaides, AN; Poulter, C; Richmond, W; Sharp, P | 1 |
Bargero, G; Borra, M; Bruno, G; Cavallo-Perin, P; D'Errico, N; Pagano, G | 1 |
Doni, A; Dräger, AM; Emeis, JJ; Kok, A; Poland, DC; Schalkwijk, CG; Stehouwer, CD; van Dijk, W; van Hinsbergh, VW | 1 |
Borejszo, I; Kinalska, I; Telejko, B; Zonenberg, A | 1 |
Artmann, GM; Bauer, U; Dikta, G; Landsmann, B; Li, AL; Schanowski-Bouvier, P; Shi, YD | 1 |
Dadiotis, L; Foussas, S; Handanis, S; Manoussakis, S; Melidonis, A; Stefanidis, A; Tournis, S; Zairis, M | 1 |
Din, G; Hu, J; Liu, Z; Wei, W; Yuan, L | 1 |
Aso, Y; Fujiwara, Y; Inukai, T; Takemura, Y | 1 |
D'Elia, JA; Gleason, RE; Keough, J; Lee, AT; Lipinska, I; Pendse, S; Roshan, B; Tofler, GH; Weinrauch, LA | 1 |
Bertolini, L; Muggeo, M; Targher, G; Zenari, L; Zoppini, G | 1 |
Aiello, LP; Chaturvedi, N; Fuller, JH; Papazoglou, N; Pokras, F; Rottiers, R | 1 |
Best, JD; Cumpston, GN; Dragicevic, G; Giles, GG; Herbert, KE; O'Dea, K; Stoney, RM | 1 |
Ariëns, RA; Ashcroft, AE; Grant, PJ; Standeven, KF; Weisel, JW; Whitaker, P | 1 |
Asakawa, H; Kawakami, F; Tokunaga, K | 1 |
Graczykowska-Koczorowska, A; Michalski, A; Ponikowska, I; Rość, D; Rydzkowski, M; Zalewska-Rydzkowska, D | 1 |
Arber, N; Avitzour, D; Berliner, S; Elishkevitz, K; Fusman, R; Koffler, M; Rotstein, R; Shapira, I; Zeltser, D | 1 |
Ascari, E; Ferrari, R; Galeazzi, G; Portera, C; Raddino, R; Sarasso, L; Scarabelli, TM; Visioli, O | 1 |
Almér, LO; Nilsson, IM; Pandolfi, M | 1 |
Jonsson, A; Wales, JK | 1 |
Almér, LA; Pandolfi, M | 1 |
Hockaday, TD | 1 |
Zöller, H | 1 |
Adelstein, S; Gomperts, ED; Hockley, J; Joffe, BI; Seftel, HC | 1 |
Coppolino, E; Cucinotta, D; Di Cesare, E; Quartarone, M; Squadrito, G | 1 |
Brown, MJ; Cullen, DR; McLaren, EH | 1 |
Di Perri, T; Forconi, S; Guerrini, M; Pecchi, S; Rossi, C | 1 |
Cormier, JM; Flessinger, JN; Lagneau, P | 1 |
Almér, LO; Lilja, B | 1 |
Arkin, CF; Ganda, OP | 1 |
Ellis, D; Orchard, TJ; Stuhldreher, WL | 1 |
Carmassi, F; De Negri, F; Mariani, G; Monzani, F; Morale, M; Navalesi, R; Puccetti, R | 1 |
Barsotti, A; Belcaro, G; Cesarone, MR; Girardello, R; Laurora, G; Marelli, C; Pomante, P; Ricci, A | 1 |
Lazúr, J; Takác, M; Tkác, I; Tkácová, R | 1 |
Ford, I; Kitchen, S; Makris, M; Preston, FE; Singh, TP; Ward, JD | 1 |
Anderson, J; Lowe, GD; MacCuish, AC; MacRury, SM; Small, M | 1 |
Das, AK; Dutta, TK | 1 |
Konen, JC; McCormick, CP; Shihabi, ZK | 1 |
Lazúr, J; Molcányová, A; Moscovic, F; Takác, M; Tkác, I | 1 |
Bielawiec, M; Kinalska, I; Kłoczko, J; Wojtukiewicz, M; Zarzycka, B | 1 |
Isogai, S; Kuboki, K; Oshima, Y; Tada, H; Takeuchi, S | 1 |
Althoff, P; Breddin, HK; Krzywanek, HJ; Schöffling, K; Uberla, K | 1 |
Belch, JJ; Flanigan, P; Forbes, CD; Frier, BM; Larkin, JG | 1 |
Ganda, OP | 1 |
Althoff, P; Breddin, HK; Kirchmaier, CM; Krzywanek, HJ; Rosak, C; Schepping, M; Schöffling, K; Uberla, K; Weichert, W; Ziemen, M | 1 |
Banga, JD; Sixma, JJ | 1 |
Ferrari, E; Fioravanti, M; Patti, AL; Solerte, SB; Viola, C | 1 |
Frank, I; Hänsgen, K; Klare, M; Podhaisky, H; Preuss, EG; Sternitzky, R | 1 |
Klieber, M; Moser, M; Winkler, R | 1 |
Gabriel, DA; Hardison, VC; Johnson, G; Keagy, BA; Lucas, CL; Ross, DW | 1 |
Jones, RL | 1 |
Ferrari, E; Solerte, SB | 1 |
Duchna, W; Gräfenstein, K | 1 |
Chmielewski, J | 1 |
Ishihama, Y; Matsunaga, K; Matsuo, T | 1 |
Anderson, J; Piercy, DA; Wardle, EN | 1 |
Banerjee, RN; Kumar, V; Sahni, AL | 1 |
Davis, E; Rozov, H | 1 |
Chakrabarti, R; Fearnley, GR | 1 |
Woolf, N | 1 |
Ivanova, NA | 1 |
Valdorf-Hansen, F | 1 |
Cohen, H; Hart, A; Thorp, JM | 1 |
Bayer, H; Ipbüker, A | 1 |
12 review(s) available for fibrinogen and Diabetic Angiopathies
Article | Year |
---|---|
Fibrinogen and fibrin clot structure in diabetes.
Topics: Animals; Blood Coagulation; Diabetes Mellitus; Diabetic Angiopathies; Fibrin; Fibrinogen; Humans; Models, Immunological; Signal Transduction | 2004 |
The haemocoagulation system and macroangiopathy in insulin dependent (type I) diabetes.
Topics: Antithrombin III; Arachidonic Acids; beta-Thromboglobulin; Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelium; Fibrinogen; Fibrinolysis; Humans; Middle Aged; Platelet Adhesiveness; Platelet Aggregation | 1984 |
[The influence of hemorrheology on the practice of clinical medicine].
Topics: Adult; Age Factors; Aged; Arterial Occlusive Diseases; Blood Physiological Phenomena; Blood Viscosity; Diabetic Angiopathies; Erythrocytes; Female; Fibrinogen; Hematocrit; Hemodilution; Hemodynamics; Hemoglobins; Humans; Hypertension; Male; Middle Aged; Models, Biological; Myocardial Infarction; Oxygen Consumption; Phlebitis; Plasmapheresis; Preoperative Care; Raynaud Disease; Rheology | 1983 |
[Risk factors of arteriosclerosis. Differential profile--various mechanisms?].
Topics: Arteriosclerosis; Cholesterol, LDL; Diabetic Angiopathies; Endothelium, Vascular; Fibrinogen; Humans; Hypertension; Lipoprotein(a); Risk Factors; Smoking | 1993 |
[Fibrinolysis and vascular diseases].
Topics: Arteriosclerosis; Cerebrovascular Disorders; Diabetic Angiopathies; Fibrinogen; Fibrinolysis; Humans; Thrombophlebitis | 1996 |
Fibrinogen and diabetes mellitus: is it time for intervention trials?
Topics: Arteriosclerosis; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Fibrinogen; Humans; Models, Biological; Predictive Value of Tests; Risk Factors; Thrombin | 1997 |
Fibrin(ogen) and diabetes mellitus: don't forget fibrinolysis.
Topics: Arteriosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Angiopathies; Fibrin; Fibrinogen; Fibrinolysis; Humans; Plasminogen Activator Inhibitor 1; Risk Factors | 1997 |
Fibrinogen, fibrinolysis and diabetes mellitus: a comment.
Topics: Arteriosclerosis; Biomarkers; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Fibrinogen; Fibrinolysis; Humans; Plasminogen Activator Inhibitor 1; Risk Factors; Tissue Plasminogen Activator | 1997 |
[Clinical implications of rheology in cardiovascular diseases].
Topics: Adult; Blood Sedimentation; Blood Viscosity; Cardiovascular Diseases; Cerebrovascular Disorders; Child; Diabetic Angiopathies; Female; Fibrinogen; Hematocrit; Hemorheology; Humans; Leukemia; Leukocytes; Malaria; Middle Aged; Myocardial Infarction; Peripheral Vascular Diseases; Prospective Studies; Risk Factors; Thrombosis | 2002 |
[Coagulation and fibrinolytic system in the vascular risks diabetes mellitus and hyperlipoproteinemia (author's transl)].
Topics: Adult; Aged; Antithrombins; Blood Coagulation; Cholesterol; Diabetes Mellitus; Diabetic Angiopathies; Female; Fibrinogen; Fibrinolysis; Humans; Hyperlipidemias; Male; Middle Aged; Platelet Aggregation; Risk; Thrombocytopenia; Triglycerides | 1978 |
Diabetes mellitus, vascular disease and thrombosis.
Topics: Blood Coagulation Factors; Blood Platelets; Blood Viscosity; Cholesterol, HDL; Coronary Disease; Diabetic Angiopathies; Erythrocyte Deformability; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Hypercholesterolemia; Hyperlipidemias; Platelet Adhesiveness | 1986 |
[Role of blood clotting and fibrinolytic disorders in diabetics in the development of pathological changes in blood vessels].
Topics: Blood Coagulation Disorders; Blood Platelet Disorders; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Factor VIII; Fibrinogen; Fibrinolysis; Humans; Insulin; Platelet Adhesiveness; Trypsin Inhibitors | 1973 |
15 trial(s) available for fibrinogen and Diabetic Angiopathies
Article | Year |
---|---|
Pleiotropic action of short-term metformin and fenofibrate treatment, combined with lifestyle intervention, in type 2 diabetic patients with mixed dyslipidemia.
Topics: Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Combined Modality Therapy; Cytokines; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Drug Therapy, Combination; Dyslipidemias; Fenofibrate; Fibrinogen; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Life Style; Metformin; Placebos; Plasminogen Activator Inhibitor 1; Risk Factors | 2009 |
Batroxobin plus aspirin reduces restenosis after angioplasty for arterial occlusive disease in diabetic patients with lower-limb ischemia.
Topics: Aged; Analysis of Variance; Angioplasty; Arterial Occlusive Diseases; Aspirin; Batroxobin; China; Constriction, Pathologic; Diabetic Angiopathies; Double-Blind Method; Drug Therapy, Combination; Female; Fibrinogen; Fibrinolytic Agents; Humans; Ischemia; Kaplan-Meier Estimate; Limb Salvage; Lower Extremity; Magnetic Resonance Angiography; Male; Middle Aged; Pilot Projects; Platelet Aggregation Inhibitors; Prospective Studies; Risk Assessment; Risk Factors; Survival Rate; Time Factors; Treatment Outcome; Ultrasonography, Doppler, Duplex | 2011 |
Effects of a 12-month physical activity counselling intervention on glycaemic control and on the status of cardiovascular risk factors in people with Type 2 diabetes.
Topics: Blood Pressure; Cardiovascular Diseases; Counseling; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Exercise; Fibrinogen; Follow-Up Studies; Humans; Oxygen Consumption; Risk Factors; Time Factors | 2004 |
Decrease in von Willebrand factor levels after a high-monounsaturated-fat diet in non-insulin-dependent diabetic subjects.
Topics: alpha-Macroglobulins; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dietary Carbohydrates; Dietary Fats, Unsaturated; Endothelium, Vascular; Fatty Acids, Monounsaturated; Female; Fibrinogen; Fibronectins; Humans; Male; Middle Aged; von Willebrand Factor | 1994 |
Diabetic microangiopathy and blood viscosity changes after pancreas and kidney transplantation.
Topics: Adult; Blood Viscosity; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Nephropathies; Female; Fibrinogen; Glycated Hemoglobin; Humans; Kidney Transplantation; Male; Middle Aged; Pancreas Transplantation; Probability; Rheology; Skin; Treatment Outcome | 1994 |
No effect of unfractioned or low molecular weight heparin treatment on markers of vascular wall and hemostatic function in incipient diabetic nephropathy.
Topics: Adult; Albuminuria; Antithrombin III; Capillaries; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Nephropathies; Double-Blind Method; Female; Fibrinogen; Hemostasis; Heparin; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Muscle, Smooth, Vascular; Peptide Fragments; Peptide Hydrolases; Placebos; Plasminogen Activator Inhibitor 1; Protein Precursors; Prothrombin; Tissue Plasminogen Activator; Triglycerides; von Willebrand Factor | 1997 |
Microcirculation in hyperglycemic patients with IDDM without diabetic complications--effect of low-dose angiotensin-converting enzyme inhibition.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Flow Velocity; Blood Pressure; Blood Viscosity; Cholesterol; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Dose-Response Relationship, Drug; Female; Fibrinogen; Glycated Hemoglobin; Heart Rate; Hematocrit; Humans; Hyperglycemia; Lipids; Male; Microcirculation; Ramipril; Triglycerides | 1998 |
Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Glucose; Blood Pressure; Body Mass Index; Calcium Channel Blockers; Cholesterol, HDL; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Follow-Up Studies; Fosinopril; Glycated Hemoglobin; Humans; Hypertension; Lipids; Male; Middle Aged; Prospective Studies; Time Factors | 1998 |
Cardiovascular outcomes in type 2 diabetes. A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study.
Topics: Adult; Aged; Bezafibrate; Carotid Arteries; Cholesterol; Cholesterol, HDL; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Electrocardiography; Exercise Test; Female; Femoral Artery; Fibrinogen; Follow-Up Studies; Humans; Hypolipidemic Agents; Lipids; Lipoproteins; Male; Middle Aged; Placebos; Time Factors; Triglycerides; Ultrasonography | 1998 |
[Some parameters of hemostasis and fibrinolysis in diabetic patients].
Topics: Adolescent; Adult; Aged; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Retinopathy; Female; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Hypertension; Male; Middle Aged; Obesity; Triglycerides | 1998 |
Hemorheology and walking of peripheral arterial occlusive diseases patients during treatment with Ginkgo biloba extract.
Topics: Aged; Arterial Occlusive Diseases; Blood Sedimentation; Blood Viscosity; Diabetic Angiopathies; Double-Blind Method; Drugs, Chinese Herbal; Erythrocyte Deformability; Female; Fibrinogen; Ginkgo biloba; Humans; Male; Middle Aged; Plants, Medicinal; Walking | 1998 |
The role of strict metabolic control by insulin infusion on fibrinolytic profile during an acute coronary event in diabetic patients.
Topics: Aged; Diabetic Angiopathies; Female; Fibrinogen; Fibrinolysis; Humans; Hypoglycemic Agents; Infusions, Intravenous; Insulin; Male; Middle Aged; Myocardial Ischemia; Plasminogen Activator Inhibitor 1; Tissue Plasminogen Activator | 2000 |
Circulating plasma vascular endothelial growth factor and microvascular complications of type 1 diabetes mellitus: the influence of ACE inhibition.
Topics: Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Retinopathy; Endothelial Growth Factors; Fibrinogen; Glycated Hemoglobin; Humans; Lisinopril; Lymphokines; Middle Aged; Placebos; Smoking; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; von Willebrand Factor | 2001 |
Fibrinolytic enhancement in diabetic microangiopathy with defibrotide.
Topics: Adult; Blood Vessels; Diabetic Angiopathies; Female; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Humans; Laser-Doppler Flowmetry; Leg; Male; Microcirculation; Middle Aged; Polydeoxyribonucleotides; Regional Blood Flow; Skin; Ultrasonography; Vasoconstriction | 1992 |
[Comparative study on the effect of diet, exercise and iodine balneotherapy on blood rheologic parameters in diabetics within the scope of a 4 week health resort stay in Bad Hall].
Topics: Arteriosclerosis; Balneology; Cholesterol; Diabetic Angiopathies; Diet, Diabetic; Female; Fibrinogen; Glycated Hemoglobin; Health Resorts; Hematocrit; Humans; Male; Middle Aged; Physical Exertion; Rheology; Triglycerides | 1985 |
117 other study(ies) available for fibrinogen and Diabetic Angiopathies
Article | Year |
---|---|
Circulating inflammatory markers and the risk of vascular complications and mortality in people with type 2 diabetes and cardiovascular disease or risk factors: the ADVANCE study.
Topics: Aged; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Humans; Interleukin-6; Male; Middle Aged; Risk Factors | 2014 |
Relation of asymmetric dimethylarginine levels to macrovascular disease and inflammation markers in type 2 diabetic patients.
Topics: Aged; Arginine; Atherosclerosis; Biomarkers; Blood Sedimentation; C-Reactive Protein; Carotid Intima-Media Thickness; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Homocysteine; Humans; Inflammation Mediators; Male; Middle Aged; Regression Analysis; Systemic Vasculitis; Up-Regulation | 2014 |
The influence of type 2 diabetes on fibrin clot properties in patients with coronary artery disease.
Topics: Aged; Aspirin; Blood Coagulation Tests; C-Reactive Protein; Case-Control Studies; Complement C3; Coronary Artery Disease; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrin; Fibrinogen; Fibrinolysis; Humans; Inflammation Mediators; Male; Microscopy, Confocal; Microscopy, Electron, Scanning; Middle Aged; Nephelometry and Turbidimetry; Platelet Aggregation Inhibitors; Registries; Risk Factors; Sex Factors; Time Factors | 2014 |
Subchronic effects of inhaled ambient particulate matter on glucose homeostasis and target organ damage in a type 1 diabetic rat model.
Topics: Animals; Biomarkers; Blood Glucose; Diabetes Complications; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Cardiomyopathies; Diabetic Nephropathies; Fibrinogen; Glycated Hemoglobin; Homeostasis; Inflammation; Inflammation Mediators; Inhalation Exposure; Interleukin-6; Male; Myocarditis; Particle Size; Particulate Matter; Rats, Sprague-Dawley; Risk Factors; Streptozocin; Time Factors; Toxicity Tests, Subchronic | 2014 |
Impact of diabetes on fibrinogen levels and its relationship with platelet reactivity and coronary artery disease: A single-centre study.
Topics: Aged; Aged, 80 and over; Blood Glucose; Blood Platelets; Coronary Angiography; Coronary Artery Disease; Diabetes Mellitus; Diabetic Angiopathies; Female; Fibrinogen; Humans; Male; Middle Aged; Platelet Aggregation; Prevalence | 2015 |
Effects of Endovascular Interventions on vWF and Fb Levels in Type 2 Diabetic Patients with Peripheral Artery Disease.
Topics: Aged; Angioplasty, Balloon; Biomarkers; Blood Coagulation; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Humans; Male; Peripheral Arterial Disease; Prothrombin Time; Stents; Time Factors; Treatment Outcome; Up-Regulation; von Willebrand Factor | 2016 |
Correlation between the plasma fibrinogen concentration and coronary heart disease severity in Moroccan patients with type 2 diabetes. Prospective study.
Topics: Aged; Aged, 80 and over; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Humans; Male; Middle Aged; Morocco; Prospective Studies; Risk Factors; Severity of Illness Index | 2016 |
The association of plasma fibrinogen concentration with diabetic microvascular complications in young adults with early-onset of type 2 diabetes.
Topics: Adult; Albumins; Biomarkers; Cardiovascular Diseases; Creatinine; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Fibrinogen; Humans; Indians, North American; Inflammation; Microcirculation | 2008 |
[Inflammation markers and endothelial disfunction in children with type 1 diabetes].
Topics: Adolescent; Atherosclerosis; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Child; Diabetes Mellitus, Type 1; Diabetic Angiopathies; E-Selectin; Endothelium, Vascular; Female; Fibrinogen; Glycated Hemoglobin; Humans; Inflammation; Male; Vascular Cell Adhesion Molecule-1 | 2010 |
Coagulation profile in diabetes and its association with diabetic microvascular complications.
Topics: Adult; Age Factors; Aged; Blood Coagulation Factors; Blood Coagulation Tests; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Neuropathies; Diabetic Retinopathy; Endothelium, Vascular; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1 | 2010 |
Microvascular complications and risk factors in patients with type 2 diabetes.
Topics: Aged; Albuminuria; Anthropometry; Antihypertensive Agents; Blood Glucose; C-Reactive Protein; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Female; Fibrinogen; Follow-Up Studies; Glycated Hemoglobin; Habits; Humans; Hypoglycemic Agents; Lipids; Male; Microcirculation; Middle Aged; Prospective Studies; Risk Factors | 2011 |
Fibrin(ogen) may be an important target for methylglyoxal-derived AGE modification in elastic arteries of humans.
Topics: Aged; Aged, 80 and over; Amino Acid Sequence; Aorta; Blotting, Western; Carotid Artery, Common; Case-Control Studies; Chromatography, Liquid; Diabetic Angiopathies; Elasticity; Female; Fibrin; Fibrinogen; Glycation End Products, Advanced; Humans; Imidazoles; Immunohistochemistry; Male; Middle Aged; Molecular Sequence Data; Necrosis; Norway; Protein Processing, Post-Translational; Proteomics; Pyruvaldehyde; Tandem Mass Spectrometry | 2011 |
Hemorheology and vascular reactivity in patients with diabetes mellitus type 2.
Topics: Adult; Aged; Blood Flow Velocity; Body Mass Index; Cerebrovascular Circulation; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Neuropathies; Erythrocyte Indices; Female; Fibrinogen; Hemorheology; Humans; Lipids; Male; Middle Aged; Middle Cerebral Artery; Posture; Skin; Toes; Ultrasonography | 2011 |
Hemorheology and heart rate variability in patients with diabetes mellitus type 2.
Topics: Adult; Aged; Blood Flow Velocity; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Neuropathies; Female; Fibrinogen; Fourier Analysis; Glycated Hemoglobin; Heart Rate; Hemorheology; Humans; Lipids; Male; Middle Aged; Posture; Rest; Stress, Mechanical | 2011 |
The association of inflammatory and fibrinolytic proteins with 5 year change in insulin clearance: the Insulin Resistance Atherosclerosis Study (IRAS).
Topics: Atherosclerosis; Body Mass Index; Cohort Studies; Diabetic Angiopathies; Female; Fibrinogen; Follow-Up Studies; Humans; Hypoglycemic Agents; Inflammation Mediators; Insulin; Insulin Resistance; Leptin; Male; Metabolic Clearance Rate; Middle Aged; Overweight; Plasminogen Activator Inhibitor 1; Prediabetic State; Prospective Studies; Risk Factors; United States | 2013 |
Leukocyte count and fibrinogen are associated with carotid and femoral intima-media thickness in a risk population for diabetes.
Topics: Adult; Aged; Analysis of Variance; Arteriosclerosis; Carotid Artery, Common; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Femoral Artery; Fibrinogen; Humans; Leukocyte Count; Male; Middle Aged; Multivariate Analysis; Risk Factors; Tunica Intima; Tunica Media | 2002 |
Fibrinogen is a marker for nephropathy and peripheral vascular disease in type 1 diabetes: studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort.
Topics: Adenine; Adult; Albuminuria; Base Sequence; Biomarkers; Cohort Studies; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; DNA Primers; Female; Fibrinogen; Guanine; Humans; Male; Peripheral Vascular Diseases; Polymorphism, Single Nucleotide; Regression Analysis | 2003 |
FIBRINOLYTIC ACTIVITY IN DIABETES MELLITUS.
Topics: Cholesterol; Coronary Disease; Diabetes Mellitus; Diabetic Angiopathies; Fibrinogen; Fibrinolysis; Humans; Thrombolytic Therapy | 1964 |
Prognostic relations between inflammatory markers and mortality in diabetic patients with non-ST elevation acute coronary syndrome.
Topics: Aged; Angina, Unstable; Biomarkers; C-Reactive Protein; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Humans; Leukocyte Count; Male; Multivariate Analysis; Myocardial Infarction; Prognosis; Spain; Survival Analysis | 2004 |
Influence of fibrinogen and hematocrit on the early outcome of angioplasty in patients with PAOD.
Topics: Aged; Angioplasty, Balloon; Arterial Occlusive Diseases; Diabetic Angiopathies; Female; Fibrinogen; Hematocrit; Humans; Ischemia; Male; Middle Aged; Peripheral Vascular Diseases; Treatment Outcome | 2004 |
Blood rheology in patients with diabetes mellitus.
Topics: Adult; Blood Glucose; Blood Viscosity; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Erythrocyte Aggregation; Female; Fibrinogen; Glycated Hemoglobin; Hemorheology; Humans; Male; Middle Aged | 2004 |
Rheological changes in diabetic microangiopathy.
Topics: Biomarkers; Blood Glucose; Blood Platelets; Blood Viscosity; Cell Adhesion; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Erythrocyte Aggregation; Erythrocyte Deformability; Female; Fibrinogen; Hematocrit; Hemorheology; Humans; Male; Middle Aged | 2004 |
Markers of inflammation in patients with coronary artery disease are also associated with glycosylated haemoglobin A1c within the normal range.
Topics: Aged; Biomarkers; Blood Glucose; Blood Sedimentation; Body Mass Index; C-Reactive Protein; Coronary Artery Disease; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Glycated Hemoglobin; Humans; Leukocyte Count; Male; Middle Aged; Reference Values | 2004 |
Inflammation-sensitive proteins and erythrocyte aggregation in atherothrombosis.
Topics: Aged; Arteriosclerosis; C-Reactive Protein; Cell Adhesion; Ceruloplasmin; Cholesterol; Cross-Sectional Studies; Diabetic Angiopathies; Erythrocyte Aggregation; Female; Fibrinogen; Humans; Immunoglobulins; Male; Middle Aged; Thrombosis | 2005 |
Fibrinogen and AER are major independent predictors of 11-year cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study.
Topics: Aged; Albuminuria; Biomarkers; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Fibrinogen; Follow-Up Studies; Humans; Italy; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Regression Analysis; Risk; Time Factors | 2005 |
The influence of type 2 diabetes on fibrin structure and function.
Topics: Blood Coagulation; Body Mass Index; Body Size; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Factor XIII; Female; Fibrin; Fibrinogen; Humans; Hypoglycemic Agents; Lipids; Male; Middle Aged; Reference Values; Risk Factors | 2005 |
Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type 1 diabetic patients without clinically manifest macroangiopathy.
Topics: Adult; Biomarkers; C-Reactive Protein; Diabetes Complications; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Endothelium, Vascular; Female; Fibrinogen; Humans; Inflammation; Intercellular Adhesion Molecule-1; Male; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II; von Willebrand Factor | 2005 |
[Cardiovascular risk factors in children with type 1 diabetes and their relationship with the glycemic control].
Topics: Adolescent; Blood Glucose; Case-Control Studies; Child; Child, Preschool; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Female; Fibrinogen; Humans; Hyperglycemia; Male; Risk Factors | 2005 |
Analysis of G(-174)C IL-6 polymorphism and plasma concentrations of inflammatory markers in patients with type 2 diabetes and peripheral arterial disease.
Topics: Aged; C-Reactive Protein; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Genetic Predisposition to Disease; Genotype; Humans; Interleukin-6; Male; Middle Aged; Peripheral Vascular Diseases; Polymorphism, Genetic; Vascular Endothelial Growth Factor A | 2006 |
Correlation of high-sensitivity C-reactive protein and plasma fibrinogen with individual complications in patients with type 2 diabetes.
Topics: Biomarkers; C-Reactive Protein; Carotid Artery, Common; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Electrocardiography; Female; Fibrinogen; Humans; Male; Middle Aged; Sensitivity and Specificity; Severity of Illness Index; Tunica Intima; Ultrasonography | 2006 |
Progression of plasminogen activator inhibitor-1 and fibrinogen levels in relation to incident type 2 diabetes.
Topics: Adult; Aged; Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Disease Progression; Female; Fibrinogen; Glucose Tolerance Test; Humans; Incidence; Male; Middle Aged; Plasminogen Activator Inhibitor 1 | 2006 |
Endothelial dysfunction correlates with plasma fibrinogen and HDL cholesterol in type 2 diabetic patients with coronary artery disease.
Topics: Cholesterol, HDL; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelium, Vascular; Fibrinogen; Humans; Middle Aged | 2007 |
Relationship between plasma sialic acid and fibrinogen concentration and incident micro- and macrovascular complications in type 1 diabetes. The EURODIAB Prospective Complications Study (PCS).
Topics: Adolescent; Adult; Albuminuria; Analysis of Variance; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Retinopathy; Europe; Female; Fibrinogen; Humans; Male; Middle Aged; Multivariate Analysis; N-Acetylneuraminic Acid | 2008 |
Fifteen coagulation and fibrinolysis parameters in diabetes mellitus and in patients with vasculopathy.
Topics: Adult; Age Factors; Aged; alpha-2-Antiplasmin; alpha-Macroglobulins; Antithrombin III; Arterial Occlusive Diseases; Blood Coagulation; Blood Coagulation Tests; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Factor VIII; Fibrinogen; Fibrinolysis; Humans; Middle Aged; Thrombin Time | 1984 |
Beta-thromboglobulin in diabetes: relationships with blood glucose and fibrinopeptide A.
Topics: Adolescent; Adult; Aged; Beta-Globulins; beta-Thromboglobulin; Blood Glucose; Diabetes Mellitus; Diabetic Angiopathies; Fibrinogen; Fibrinopeptide A; Humans; Middle Aged | 1981 |
[Thrombosis and diabetic angiopathy].
Topics: Adenosine Diphosphate; beta-Thromboglobulin; Blood Coagulation Factors; Blood Platelets; Diabetic Angiopathies; Fibrinogen; Fibrinolysis; Humans; Platelet Aggregation; Thrombosis | 1982 |
Effects of guar on plasma viscosity and related parameters in diabetic children.
Topics: Adolescent; Blood Proteins; Blood Viscosity; Child; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Dietary Fiber; Fabaceae; Female; Fibrinogen; Humans; Insulin; Male; Plants, Medicinal; Serum Albumin | 1981 |
[Longitudinal studies on the prognostic significance of plasma fibrinogen in diabetes mellitus].
Topics: Coronary Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Humans; Hypertension; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Prognosis | 1984 |
[Sterol-fibrinogen blood complexes in patients with diabetes mellitus and associated ischemic heart disease].
Topics: Adult; Aged; Coronary Disease; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Fibrinogen; Humans; Middle Aged; Sterols | 1983 |
[Use of pentoxifylline in diabetes with intermittent claudication].
Topics: Cholesterol; Diabetic Angiopathies; Erythrocytes; Fibrinogen; Glycated Hemoglobin; Humans; Intermittent Claudication; Lipids; Pentoxifylline; Theobromine; Ultrafiltration | 1983 |
[Lipid-metabolic and blood coagulation factors in chronic peripheral arteriopathies].
Topics: Adult; Aged; Antithrombin III; Arterial Occlusive Diseases; Chronic Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Humans; Lipids; Male; Middle Aged; Thrombocytosis | 1983 |
[Contact (prekallikrein) and fibrinolytic (plasminogen/antiplasmin value) system in the physiopathology of vascular complications of diabetes].
Topics: Adolescent; Adult; Aged; alpha-2-Antiplasmin; Antithrombin III; Diabetes Mellitus; Diabetic Angiopathies; Factor VIII; Fibrinogen; Fibrinolysis; Humans; Kallikreins; Middle Aged; Plasminogen; Prekallikrein | 1982 |
Plasma soluble fibrin monomer complexes in diabetic microangiopathy.
Topics: Adult; Aged; Blood Urea Nitrogen; Creatinine; Diabetic Angiopathies; Diabetic Retinopathy; Female; Fibrin; Fibrinogen; Humans; Macromolecular Substances; Male; Middle Aged; Proteinuria; Solubility | 1982 |
[Mechanisms responsible for hyperfibrinogenaemia in the diabetics ].
Topics: Adolescent; Adult; Age Factors; Aged; Child; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Retinopathy; Female; Fibrinogen; Glycated Hemoglobin; Humans; Male; Middle Aged | 1982 |
Increased adhesion of erythrocytes to endothelial cells in diabetes mellitus and its relation to vascular complications.
Topics: Adult; Aged; Blood Vessels; Blood Viscosity; Cell Adhesion; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Endothelium; Erythrocytes; Female; Fibrinogen; Fibronectins; Humans; In Vitro Techniques; Male; Middle Aged; Plastics | 1981 |
Physical factors important in the development of atherosclerosis in diabetes.
Topics: Arteries; Arteriosclerosis; Blood Viscosity; Diabetic Angiopathies; Endothelium; Fibrinogen; Humans; Reference Values; Regional Blood Flow; Risk; Stress, Mechanical | 1981 |
[Study of behaviour of fibrinogen and of some glycoproteins in arteriosclerotic clinical situations (author's transl)].
Topics: Acute Disease; Arteriosclerosis; Chronic Disease; Coronary Disease; Diabetic Angiopathies; Fibrinogen; Glycoproteins; Humans; Hyperlipoproteinemias; Myocardial Infarction | 1980 |
[Blood viscosimetric factors in cardiovascular pathology].
Topics: Angina Pectoris; Arterial Occlusive Diseases; Blood Flow Velocity; Blood Viscosity; Cardiovascular Diseases; Diabetic Angiopathies; Fibrinogen; Hematocrit; Humans; Leg; Myocardial Infarction; Vascular Diseases | 1980 |
Skin capillary circulation is more impaired in the toes of diabetic than non-diabetic patients with peripheral vascular disease.
Topics: Aged; Blood Glucose; Capillaries; Case-Control Studies; Diabetic Angiopathies; Female; Fibrinogen; Glycated Hemoglobin; Hematocrit; Hemoglobins; Humans; Laser-Doppler Flowmetry; Male; Microcirculation; Reference Values; Skin; Skin Temperature; Toes; Ultrasonography; Vascular Diseases | 1995 |
Hemostasis variables in type I diabetic patients without demonstrable vascular complications.
Topics: Adenosine Diphosphate; Adult; Blood Coagulation Factors; Blood Pressure; Blood Viscosity; C-Peptide; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Collagen; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Female; Fibrinogen; Glycated Hemoglobin; Hemostasis; Humans; Male; Platelet Aggregation; Platelet Count; Reference Values; Triglycerides | 1993 |
Hypercoagulability and high lipoprotein(a) levels in patients with type II diabetes mellitus.
Topics: Aged; alpha-2-Antiplasmin; Antithrombin III; Blood Coagulation Disorders; Body Mass Index; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Disease Susceptibility; Female; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Japan; Lipoprotein(a); Male; Middle Aged; Peptide Hydrolases; Plasminogen Activator Inhibitor 1; Risk Factors; Tissue Plasminogen Activator | 1996 |
Risk factor analyses for macrovascular complication in nonobese NIDDM patients. Multiclinical Study for Diabetic Macroangiopathy (MSDM).
Topics: Aged; Blood Pressure; Cholesterol; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Humans; Japan; Male; Middle Aged; Regression Analysis; Risk Factors; Triglycerides | 1996 |
Influence of smoking on the survival rate of diabetic patients requiring hemodialysis.
Topics: Blood Pressure; Cardiovascular Diseases; Cerebrovascular Disorders; Cholesterol; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Female; Fibrinogen; Glycated Hemoglobin; Humans; Kidney Failure, Chronic; Male; Middle Aged; Prevalence; Renal Dialysis; Retrospective Studies; Risk Assessment; Risk Factors; Smoking; Survival Rate; Time Factors; Triglycerides | 1996 |
Angiopathy affects circulating endothelin-1 levels in type 2 diabetic patients.
Topics: Biomarkers; Blood Glucose; Blood Pressure; Body Mass Index; Cholesterol; Creatine; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelins; Female; Fibrinogen; Humans; Male; Middle Aged; Reference Values; Regression Analysis; Triglycerides; Urea | 1995 |
Beta-fibrinogen gene-455 G/A polymorphism and fibrinogen levels. Risk factors for coronary artery disease in subjects with NIDDM.
Topics: Adenine; Aged; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Genotype; Guanine; Humans; Hypertension; Male; Middle Aged; Polymorphism, Genetic; Risk Factors | 1996 |
The influence of diabetes on the vasomotor responses of saphenous vein and the development of infra-inguinal vein graft stenosis.
Topics: Aged; Aged, 80 and over; Amputation, Surgical; Blood Vessel Prosthesis; Bradykinin; Calcimycin; Collagen; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelium, Vascular; Female; Fibrinogen; Humans; In Vitro Techniques; Indomethacin; Ischemia; Leg; Male; Microscopy, Electron; Middle Aged; NG-Nitroarginine Methyl Ester; Postoperative Complications; Saphenous Vein; Time Factors; Vascular Diseases; Vascular Surgical Procedures; Vasodilation | 1997 |
Diabetic microangiopathy: lupus anticoagulant dependent thrombotic tendency in type 1 (insulin-dependent) diabetes mellitus.
Topics: Adult; Aged; Blood Coagulation; Blood Pressure; Body Mass Index; Creatinine; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Female; Fibrinogen; Humans; Lupus Coagulation Inhibitor; Male; Middle Aged; Thrombosis | 1997 |
Haemorheology in insulin-dependent diabetes is still normal five years after onset of the disease.
Topics: Adolescent; Age Factors; Blood Viscosity; Case-Control Studies; Chi-Square Distribution; Child; Child, Preschool; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Disease Progression; Female; Fibrinogen; Follow-Up Studies; Hematocrit; Hemorheology; Humans; Male; Prospective Studies; Sex Factors; Sweden | 1997 |
Fibrinogen and von Willebrand factor in IDDM: relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: the EURODIAB IDDM Complications Study.
Topics: Adult; Albuminuria; Blood Glucose; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Europe; Female; Fibrinogen; Glycated Hemoglobin; Humans; Male; Risk Factors; Smoking; Triglycerides; von Willebrand Factor | 1997 |
[Fibrinogen and diabetic microangiopathy].
Topics: Adolescent; Adult; Blood Pressure; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Nephropathies; Female; Fibrinogen; Humans; Male; Middle Aged; Platelet Aggregation | 1997 |
Role of leukocytes in diabetic microcirculatory disturbances.
Topics: Diabetes Mellitus, Type 2; Diabetic Angiopathies; Fibrinogen; Hematocrit; Hemorheology; Humans; Leukocytes; Membrane Fluidity; Microcirculation; Microscopy, Video; Plasma; Pressure; Reproducibility of Results; Suspensions | 1997 |
Fibrinogen and albuminuria are related to the presence and severity of peripheral arterial disease in women with type 2 diabetes mellitus.
Topics: Aged; Albuminuria; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Humans; Lipids; Middle Aged; Peripheral Vascular Diseases; Regression Analysis; Risk Factors | 1997 |
Total plasma antioxidant capacity predicts thrombosis-prone status in NIDDM patients.
Topics: Antioxidants; Ascorbic Acid; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Peptide Fragments; Predictive Value of Tests; Protein Precursors; Prothrombin; Reference Values; Regression Analysis; Risk Factors; Thrombosis; Uric Acid; Vitamin A; Vitamin E | 1997 |
Retrospective analysis of long-term hemorheologic effects of pentoxifylline in diabetic patients with angiopathic complications.
Topics: Adult; Aged; Albuminuria; Blood Pressure; Blood Viscosity; Diabetic Angiopathies; Female; Fibrinogen; Humans; Male; Pentoxifylline; Retrospective Studies; Rheology; Vasodilator Agents | 1997 |
Glycaemic control and cardiovascular risk factors in type 2 diabetes: a population-based study.
Topics: Blood Glucose; Cholesterol; Cohort Studies; Diabetes Complications; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Glycated Hemoglobin; Humans; Hypertension; Hypoglycemic Agents; Male; Obesity; Risk Factors; Triglycerides | 1998 |
Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation.
Topics: Adult; Albuminuria; Biomarkers; Body Mass Index; C-Reactive Protein; Diabetes Mellitus, Type 1; Diabetic Angiopathies; E-Selectin; Endothelium, Vascular; Female; Fibrinogen; Glycated Hemoglobin; Humans; Inflammation; Male; Orosomucoid; Phospholipases A; Reference Values; Regression Analysis; Vascular Cell Adhesion Molecule-1; von Willebrand Factor | 1999 |
Variations and clinical significance of coagulation and fibrinolysis parameters in patients with diabetes mellitus.
Topics: Adult; Aged; Antithrombin III; Blood Coagulation; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Thrombophilia | 1998 |
Thermographic measurement of skin temperature recovery time of extremities in patients with type 2 diabetes mellitus.
Topics: Analysis of Variance; Arteriosclerosis; Blood Pressure; Cold Temperature; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Humans; Japan; Male; Middle Aged; Neural Conduction; Plasminogen Activator Inhibitor 1; Reference Values; Regression Analysis; Skin Temperature; Thermography; Time Factors; Toes | 2000 |
Fibrinogen and factor VII levels improve with glycemic control in patients with type 1 diabetes mellitus who have microvascular complications.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Factor VII; Fibrinogen; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Middle Aged | 2001 |
Elevated levels of interleukin-6 in young adults with type 1 diabetes without clinical evidence of microvascular and macrovascular complications.
Topics: Adult; Blood Pressure; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Enzyme-Linked Immunosorbent Assay; Fibrinogen; Humans; Interleukin-6; Reference Values | 2001 |
Insulin resistance as a major determinant of increased coronary heart disease risk in postmenopausal women with Type 2 diabetes mellitus.
Topics: Absorptiometry, Photon; Adipose Tissue; Aged; Albuminuria; Blood Glucose; Blood Pressure; Cholesterol; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Electrocardiography; Factor VII; Female; Fibrinogen; Homeostasis; Humans; Insulin; Insulin Resistance; Lipoproteins; Lipoproteins, LDL; Middle Aged; Models, Biological; Plasminogen Activator Inhibitor 1; Postmenopause; Proinsulin; Risk Factors; Triglycerides | 2001 |
The effect of dimethylbiguanide on thrombin activity, FXIII activation, fibrin polymerization, and fibrin clot formation.
Topics: Blood Coagulation; Cardiotonic Agents; Diabetic Angiopathies; Enzyme Activation; Factor XIII; Fibrin; Fibrinogen; Humans; Hypoglycemic Agents; Kinetics; Metformin; Thrombin | 2002 |
Impaired hemorheological properties in diabetic patients with lower limb arterial ischaemia.
Topics: Adult; Aged; Arteries; Blood Gas Monitoring, Transcutaneous; Blood Viscosity; Case-Control Studies; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Erythrocyte Aggregation; Female; Fibrinogen; Hemorheology; Humans; Hypoxia; Ischemia; Leg; Male; Middle Aged; Serum Albumin | 2001 |
Relationship of abdominal fat with metabolic disorders in diabetes mellitus patients.
Topics: Abdomen; Adipose Tissue; Aged; Albuminuria; Antithrombin III; Blood Coagulation Disorders; Blood Pressure; Body Composition; Cholesterol, HDL; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Female; Fibrinogen; Humans; Insulin; Male; Middle Aged; Peptide Hydrolases; Regression Analysis; Sex Characteristics; Triglycerides; Viscera | 2002 |
[Plasminogen activators (t-PA and u-PA) and other fibrinolysis parameters in patients with atherosclerosis obliterans and diabetic macroangiopathy].
Topics: Adult; Aged; Antithrombins; Arteriosclerosis Obliterans; Case-Control Studies; Diabetic Angiopathies; Enzyme-Linked Immunosorbent Assay; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Leg; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Serine Proteinase Inhibitors; Serum Globulins; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator | 2001 |
Rheological determinants of red blood cell aggregation in diabetic patients in relation to their metabolic control.
Topics: Acute-Phase Proteins; Blood Glucose; Blood Sedimentation; C-Reactive Protein; Cell Adhesion; Cell Aggregation; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Erythrocytes; Female; Fibrinogen; Hemorheology; Humans; In Vitro Techniques; Leukocyte Count; Male; Sensitivity and Specificity; Triglycerides | 2002 |
Diabetic retinopathy and the fibrinolytic system.
Topics: Age Factors; Aged; Alpha-Globulins; Blood Vessels; Chronic Disease; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Retinopathy; Enzyme Activation; Female; Fibrinogen; Fibrinolysis; Humans; Macroglobulins; Male; Obesity; Plasminogen; Time Factors | 1975 |
Blood glycoprotein levels in diabetes mellitus.
Topics: alpha-Macroglobulins; Ceruloplasmin; Diabetes Mellitus; Diabetic Angiopathies; Fibrinogen; Glycoproteins; Haptoglobins; Humans; Lipoproteins, LDL | 1976 |
Fibrinolysis and diabetic retinopathy.
Topics: alpha-Macroglobulins; Arm; Diabetic Angiopathies; Diabetic Retinopathy; Endothelium; Fibrinogen; Fibrinolysis; Humans; Plasminogen Activators; Veins | 1976 |
Direct animal and indirect human evidence of altered platelet function in diabetics.
Topics: Adenosine Diphosphate; Adolescent; Adult; Aged; Animals; beta-Thromboglobulin; Blood Glucose; Blood Platelets; Blood Vessels; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Female; Fibrinogen; Humans; Insulin; Male; Middle Aged; Platelet Aggregation; Platelet Count; Prospective Studies; Prothrombin Time; Rabbits | 1979 |
Haemostatic factors in Black and White diabetics.
Topics: Adult; Aged; Black People; Blood Coagulation Factors; Blood Glucose; Cholesterol; Diabetic Angiopathies; Factor VIII; Female; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; South Africa; Triglycerides; White People | 1979 |
[Behavior of some indices of fibrinolysis (fibrinogen, FDP, plasminogen) in mature diabetics].
Topics: Adult; Diabetes Mellitus; Diabetic Angiopathies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Lipids; Male; Middle Aged; Plasminogen | 1979 |
Coagulation abnormalities in diabetic coma before and 24 hours after treatment.
Topics: Adolescent; Adult; Aged; Blood Coagulation Disorders; Blood Glucose; Diabetic Angiopathies; Diabetic Coma; Fibrinogen; Humans; Middle Aged; Prothrombin Time | 1979 |
[Changes in systemic blood viscosity in subjects with regional chronic vasculopathies during spontaneous and induced ischemia].
Topics: Adult; Angina Pectoris; Arterial Occlusive Diseases; Blood Viscosity; Chronic Disease; Coronary Disease; Diabetic Angiopathies; Diabetic Retinopathy; Female; Fibrinogen; Hematocrit; Humans; Male; Middle Aged; Myocardial Infarction; Osmotic Fragility | 1977 |
[The place of complementary examinations in the study of a leg ulcer].
Topics: Angiography; Arteriosclerosis; Arteriosclerosis Obliterans; Diabetic Angiopathies; Fibrinogen; Humans; Leg Ulcer; Phlebitis; Phlebography; Thrombosis; Ultrasonography; Varicose Ulcer | 1975 |
Fibrinolysis in relation to circulation through the legs in diabetics.
Topics: Adult; Age Factors; Aged; Arteries; Blood Flow Velocity; Blood Pressure; Blood Vessels; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Retinopathy; Female; Fibrin; Fibrinogen; Fibrinolysis; Humans; Leg; Male; Middle Aged; Obesity; Plasminogen; Plethysmography, Impedance; Regional Blood Flow; Thrombophlebitis | 1975 |
Hyperfibrinogenemia. An important risk factor for vascular complications in diabetes.
Topics: Analysis of Variance; Blood Glucose; Cholesterol; Cholesterol, HDL; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Glycated Hemoglobin; Humans; Hypertension; Male; Middle Aged; Multivariate Analysis; Obesity; Reference Values; Risk Factors; Triglycerides | 1992 |
The association of waist-hip ratio and risk factors for development of IDDM complications in an IDDM adult population.
Topics: Abdomen; Adipose Tissue; Adolescent; Adult; Age Factors; Aged; Blood Pressure; Body Weight; Cardiovascular Diseases; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Female; Fibrinogen; Hip; Humans; Insulin Resistance; Lipids; Lipoproteins; Male; Middle Aged; Multivariate Analysis; Risk Factors; Triglycerides | 1992 |
Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus.
Topics: Adult; Amino Acid Sequence; Antithrombin III; Blood Coagulation; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Factor VII; Female; Fibrinogen; Fibrinolysis; Humans; Male; Molecular Sequence Data; Oligopeptides; Peptide Hydrolases; Plasminogen Activator Inhibitor 1; Plasminogen Activators; Substrate Specificity | 1992 |
Hematologic changes in type 2 diabetic patients with various localizations of peripheral vascular disease.
Topics: Arteriosclerosis Obliterans; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Hematocrit; Hemoglobinometry; Humans; Ischemia; Leg; Leukocyte Count; Male; Middle Aged; Platelet Count | 1992 |
Activation of coagulation in diabetes mellitus in relation to the presence of vascular complications.
Topics: Adult; Blood Coagulation; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Factor VII; Factor VIIa; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinopeptide A; Glycated Hemoglobin; Hemostasis; Humans; Male; Middle Aged; Smoking | 1991 |
Evaluation of red cell deformability by a filtration method in type 1 and type 2 diabetes mellitus with and without vascular complications.
Topics: Adult; Aged; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Erythrocyte Deformability; Female; Fibrinogen; Filtration; Glycated Hemoglobin; Hematocrit; Hemoglobins; Humans; Leukocyte Count; Male; Middle Aged; Reference Values; Serum Globulins; Smoking | 1990 |
Haemorheology in diabetes.
Topics: Blood Viscosity; Diabetes Mellitus; Diabetic Angiopathies; Erythrocyte Deformability; Fibrinogen; Humans; Insulin; Rheology; Serum Globulins | 1990 |
Plasma fibrinogen levels in type II diabetics.
Topics: Albuminuria; Blood Glucose; Cholesterol; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Fibrinogen; Glycated Hemoglobin; Humans; Immunoassay; Risk Factors | 1990 |
Different levels of cardiovascular risk factors in type-2 diabetic patients with lower limb proximal and distal vessel macroangiopathy.
Topics: Apolipoproteins B; Cholesterol; Cholesterol, LDL; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Fibrinogen; Humans; Leg; Risk Factors; Ultrasonography | 1990 |
Plasma factor XIII and some other haemostasis parameters in patients with diabetic angiopathy.
Topics: Adult; Aged; alpha 1-Antitrypsin; alpha-Macroglobulins; Antithrombin III; Blood Coagulation; Complement C1 Inactivator Proteins; Diabetic Angiopathies; Diabetic Nephropathies; Factor XIII; Fibrinogen; Humans; Middle Aged; Plasminogen | 1986 |
Increased intraglomerular thrombin formation in diabetic microangiopathy.
Topics: Adult; Aged; Blood Pressure; Diabetic Angiopathies; Diabetic Retinopathy; Female; Fibrin; Fibrinogen; Humans; Kidney Glomerulus; Male; Middle Aged; Renal Artery; Renal Veins; Thrombin | 1989 |
PARD: platelet aggregation as a risk factor in diabetics: results of a prospective study.
Topics: Aged; beta-Thromboglobulin; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Factor VIII; Female; Fibrinogen; Glycosuria; Humans; Male; Middle Aged; Platelet Aggregation; Prospective Studies; Reference Values; Risk; Sex Factors | 1985 |
Microvascular disease and limited joint mobility in diabetes. A comparison of fibrinolysis and prostacyclin in diabetes and systemic sclerosis.
Topics: Adult; Aged; Antithrombin III; Diabetic Angiopathies; Epoprostenol; Female; Fibrinogen; Fibrinolysis; Humans; Joint Diseases; Male; Middle Aged; Movement; Plasminogen Activators; Scleroderma, Systemic | 1988 |
Markedly increased erythrocyte sedimentation rate, hyperfibrinogenemia, and peripheral vascular disease in diabetic patients: association with clinical implications.
Topics: Adult; Aged; Blood Sedimentation; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Female; Fibrinogen; Humans; Male; Middle Aged | 1988 |
Haemostasiological parameters as risk factor for new arterial occlusions in diabetics.
Topics: Aged; Arterial Occlusive Diseases; Blood Coagulation Tests; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Humans; Male; Middle Aged; Platelet Aggregation; von Willebrand Factor | 1986 |
Effects of long-term treatment (4 years) with pentoxifylline on haemorheological changes and vascular complications in diabetic patients.
Topics: Adult; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Erythrocyte Deformability; Female; Fibrinogen; Humans; Male; Middle Aged; Pentoxifylline; Theobromine | 1987 |
[Hemorheologic studies for evaluating microcirculation in patients with peripheral arterial circulatory disorders and diabetes mellitus].
Topics: Adult; Aged; Arterial Occlusive Diseases; Blood Viscosity; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Erythrocyte Aggregation; Erythrocyte Deformability; Fibrinogen; Hematocrit; Humans; Ischemia; Leg; Male; Microcirculation; Middle Aged; Rheology | 1986 |
Viscous factors in peripheral tissue perfusion.
Topics: Blood Circulation; Blood Flow Velocity; Blood Viscosity; Diabetic Angiopathies; Erythrocyte Deformability; Fibrinogen; Hematocrit; Humans | 1985 |
Fibrinopeptide-A in diabetes mellitus. Relation to levels of blood glucose, fibrinogen disappearance, and hemodynamic changes.
Topics: Adolescent; Adult; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Fibrinopeptide A; Glucose; Hemodynamics; Humans; Male; Middle Aged | 1985 |
Diabetic retinal vascular complications and erythrocyte filtrability; results of a 2-year follow-up study with pentoxifylline.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Erythrocyte Deformability; Female; Fibrinogen; Follow-Up Studies; Glycated Hemoglobin; Humans; Male; Middle Aged; Pentoxifylline; Proteinuria; Theobromine; Time Factors | 1985 |
[Biochemical aspects of the pathogenesis of the late diabetic syndrome].
Topics: Apoproteins; Blood Glucose; Collagen; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Fibrinogen; Glycated Hemoglobin; Humans; Membrane Proteins; Myelin Proteins; Serum Albumin | 1985 |
[Role of plasma fibrinogen in diabetes mellitus].
Topics: Adolescent; Adult; Age Factors; Aged; Diabetes Mellitus; Diabetic Angiopathies; Female; Fibrinogen; Glucose Tolerance Test; Humans; Male; Middle Aged | 1972 |
Some chemical indices of diabetic vascular disease.
Topics: Cholesterol; Diabetic Angiopathies; Diabetic Retinopathy; Fibrinogen; Glycoproteins; Humans; Lipids; Macroglobulins; Triglycerides | 1973 |
Fibrinocoagulopathy in maturity onset diabetes mellitus and atherosclerosis.
Topics: Adolescent; Adult; Aged; Arteriosclerosis; Blood Coagulation Disorders; Blood Coagulation Tests; Diabetes Complications; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Fibrin; Fibrinogen; Half-Life; Humans; Iodine Radioisotopes; Middle Aged | 1973 |
The effects of xanthinol nicotinate on the small blood vessels.
Topics: Amino Alcohols; Arteriosclerosis; Blood Viscosity; Conjunctiva; Diabetic Angiopathies; Erythrocyte Aggregation; Female; Fibrinogen; Humans; Hypertension; Ischemia; Male; Microcirculation; Middle Aged; Nicotinic Acids; Theophylline; Vascular Diseases; Vasodilator Agents | 1973 |
Pharmacological fibrinolysis in diabetes mellitus.
Topics: Blood Glucose; Diabetes Mellitus; Diabetic Angiopathies; Drug Interactions; Drug Therapy, Combination; Ethylestrenol; Female; Fibrinogen; Fibrinolysis; Humans; Male; Obesity; Phenformin; Thrombosis | 1974 |
Diabetes and atherosclerosis.
Topics: Adult; Age Factors; Aorta; Arteries; Arteriosclerosis; Autopsy; Cholesterol; Coronary Disease; Coronary Vessels; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Female; Fibrinogen; Humans; Insulin; Lipid Metabolism; Lipoproteins; Male; Middle Aged; Platelet Adhesiveness; Sex Factors; Thrombosis; Triglycerides | 1971 |
[Some indices of the blood coagulation system and thrombus-formation in patients with diabetes mellitus].
Topics: Adolescent; Adult; Aged; Arteriosclerosis; Blood Cell Count; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Factor XIII; Fibrinogen; Fibrinolysis; Heparin; Humans; Middle Aged; Prothrombin; Thrombelastography; Thrombin; Thrombosis | 1971 |
Coagulability in diabetics.
Topics: Adolescent; Adult; Blood Coagulation; Blood Coagulation Tests; Calcification, Physiologic; Child; Child, Preschool; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Eye Manifestations; Factor V; Factor VII; Female; Fibrinogen; Heparin; Humans; Male; Methods; Middle Aged; Thrombin | 1967 |
Lipoprotein and fibrinogen studies in diabetes.
Topics: Adult; Aged; Capillary Fragility; Cholesterol; Diabetes Mellitus; Diabetic Angiopathies; Female; Fibrinogen; Humans; Lipoproteins; Male; Middle Aged; Triglycerides | 1971 |
[Variations in fibrinolytic activity and fibrinogen caused by xanthinol nicotinate in cases of diabetes mellitus with peripheral vascular lesions].
Topics: Adult; Aged; Diabetic Angiopathies; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Nicotinic Acids; Xanthines | 1969 |